Therapeutics: ADAM metallopeptidase domain 10 (ADAM10); amyloid precursor protein (APP)

In vitro and mouse studies suggest inhibiting ADAM10 could help treat fragile X syndrome. Levels of soluble APPα, an ADAM10-mediated cleavage product of APP, were higher in lymphoblastoid cells from f...